DanCann Pharma A/S: Flagging announcement
COPENHAGEN, Denmark, 30 November 2023, DanCann Pharma A/S ("DanCann" or the "Company"), a Danish company powered by cannabinoids, hereby announces that the shareholder Xignotus Capital ApS’ (“Xignotus”) holding in the Company, as a result of the conversion made by Nordic Growth Opportunities 2 (“NGO2”), has crossed the flagging limit of 5 percent ownership. Additionally, NGO2, through this transaction, has exceeded the flagging limit of 25 percent ownership.As a result of the conversion, NGO2 obtains a shareholding of 37,758,594 shares, while Xignotus maintains its historical number of 5,